Guidance for market authorization requirements...
Dataset description:
This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. The guidance explains recent...
Source: Guidance for market authorization requirements for COVID-19 drugs: Overview
There are no views created for this dataset yet.
Additional Information
| Field | Value |
|---|---|
| Data last updated | October 20, 2025 |
| Metadata last updated | October 20, 2025 |
| Created | October 20, 2025 |
| Format | HTML |
| License | Open Government Licence - Canada |
| Has views | False |
| Id | 1c329ea6-4b07-444d-9d8d-5d6686f9f39b |
| Package id | 56002d1c-a30d-41bd-89e9-8888892c7565 |
| Position | 1 |
| State | active |